General MedicationsOPHTHALMICGeneric
PRED-G
GENTAMICIN SULFATE; PREDNISOLONE ACETATE
Standard Dose
EQ 0.3% BASE;0.6%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview PRED-G is listed in Drugs@FDA under application 050612 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE; PREDNISOLONE ACETATE Form and strength OINTMENT;OPHTHALMIC - EQ 0.3% BASE;0.6% Sponsor ALLERGAN Submission history Latest submission status date: 2018-06-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview PRED-G is listed in Drugs@FDA under application 050612 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE; PREDNISOLONE ACETATE Form and strength OINTMENT;OPHTHALMIC - EQ 0.3% BASE;0.6% Sponsor ALLERGAN Submission history Latest submission status date: 2018-06-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.